Logo

OPCH

Option Care Health, Inc.

OPCH

Option Care Health, Inc. • NASDAQ
$31.08 ▲ 0.19% (+0.06)
Market Cap $5.12 B
52w High $35.53
52w Low $22.29
Dividend Yield 0%
P/E 24.67
Volume 702.79K
Outstanding Shares 164.75M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.435B ▲ $188.395M ▲ $51.816M ▲ 3.611% ▲ $0.32 ▲ $155.631M ▲
Q2-2025 $1.416B ▲ $186.333M ▲ $50.523M ▲ 3.568% ▲ $0.31 ▲ $100.261M ▲
Q1-2025 $1.333B ▼ $183.864M ▲ $46.742M ▼ 3.507% ▼ $0.28 ▼ $93.16M ▼
Q4-2024 $1.346B ▲ $181.342M ▲ $60.133M ▲ 4.466% ▲ $0.36 ▲ $109.397M ▲
Q3-2024 $1.279B $171.658M $53.856M 4.212% $0.32 $101.126M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $309.822M ▲ $3.48B ▲ $2.121B ▲ $1.359B ▼
Q2-2025 $198.818M ▲ $3.383B ▲ $2.023B ▲ $1.36B ▲
Q1-2025 $171.372M ▼ $3.309B ▼ $1.958B ▼ $1.351B ▼
Q4-2024 $412.565M ▼ $3.422B ▼ $2.018B ▲ $1.404B ▼
Q3-2024 $483.026M $3.428B $2.001B $1.426B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $51.816M ▲ $139.437M ▲ $-11.724M ▼ $-16.709M ▲ $111.004M ▲ $157.903M ▲
Q2-2025 $50.523M ▲ $90.333M ▲ $-9.02M ▲ $-53.867M ▲ $27.446M ▲ $81.238M ▲
Q1-2025 $46.742M ▼ $-7.214M ▼ $-126.693M ▼ $-107.286M ▼ $-241.193M ▼ $-16.585M ▼
Q4-2024 $60.133M ▲ $36.122M ▼ $-11.204M ▼ $-95.379M ▼ $-70.461M ▼ $25.782M ▼
Q3-2024 $53.856M $160.399M $-9.669M $-44.576M $106.154M $150.73M

Revenue by Products

Product Q2-2015Q1-2025Q2-2025Q3-2025
Reportable Segment
Reportable Segment
 $0 ▲$1.33Bn ▲$1.42Bn ▲$1.44Bn ▲
PBM Services
PBM Services
 $20.00M ▲$0 ▼$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Option Care Health shows a clear pattern of steady growth. Revenue has climbed each year, and the company has moved from roughly breakeven a few years ago to being consistently profitable. Operating profits have improved over time, reflecting better scale and efficiency. However, the most recent year shows a bit of pressure on profitability: earnings are still healthy, but a touch lower than the prior year despite higher sales, suggesting rising costs or pricing pressure that investors may want to monitor.

Balance Sheet

Balance Sheet The balance sheet looks generally solid and gradually stronger over time. Total assets have been growing, and cash on hand has improved meaningfully from earlier years. Debt levels have stayed fairly stable, rather than rising alongside growth, which helps keep financial risk contained. Shareholders’ equity has also trended upward, indicating that the company is building value rather than consuming it. Overall, it appears to be a reasonably well-capitalized business with manageable leverage.

Cash Flow

Cash Flow Cash generation is a notable strength. The company has produced positive operating cash flow for several years, and that cash has grown as the business has scaled. After only modest spending on capital investments, free cash flow remains solidly positive, pointing to a relatively asset-light model. This gives management flexibility to fund technology investments, acquisitions, or debt reduction without needing to rely heavily on new borrowing or equity issuance.

Competitive Edge

Competitive Edge Option Care Health holds a strong competitive position as the largest independent home and alternate-site infusion provider in the country. Its nationwide presence, deep clinical expertise in complex therapies, and extensive relationships with major insurers and hospital systems create meaningful barriers for smaller or newer rivals. Competition from healthcare giants still exists, but some large players have pulled back in certain infusion areas, which opens room for Option Care Health to gain share. Its independence can be an advantage, allowing it to partner flexibly across many payers and health systems.

Innovation and R&D

Innovation and R&D The company leans heavily on technology partnerships instead of traditional in-house R&D. It has modernized its operations with cloud-based tools for clinicians, advanced pharmacy and infusion software, and now an artificial intelligence platform aimed at optimizing scheduling, onboarding, and supply chain. These initiatives are designed to lift efficiency, improve care quality, and support value-based care arrangements. Continued expansion into new therapies, better data analytics, and selective acquisitions are all central to its innovation and growth strategy.

Summary

Overall, Option Care Health combines steady growth, consistent profitability, and strong cash generation with a defensible position in a niche of healthcare that benefits from the shift to home-based care. The main positives are its national scale, clinical specialization, strong payer and provider relationships, and technology-driven efficiency push. Key watchpoints include maintaining margins in the face of cost and reimbursement pressures, successfully executing on its AI and software rollouts, and navigating regulatory and payer changes. The business profile is that of a scaled, cash-generative healthcare services company operating in an area with structural tailwinds but ongoing operational and policy risks.

NEWS

November 3, 2025 · 4:05 PM UTC

Option Care Health to Participate in Upcoming Investor Conferences

Read more

October 30, 2025 · 7:00 AM UTC

Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025

Read more

September 25, 2025 · 4:05 PM UTC

Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call

Read more